Tue, April 3, 2018
Mon, April 2, 2018
Thu, March 29, 2018
Wed, March 28, 2018
Tue, March 27, 2018
Mon, March 26, 2018
Fri, March 23, 2018
Thu, March 22, 2018
Wed, March 21, 2018
Tue, March 20, 2018
Mon, March 19, 2018
Fri, March 16, 2018
Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018
Fri, March 9, 2018
Thu, March 8, 2018

Alethia Young Maintained (ASND) at Buy with Increased Target to $78 on, Mar 20th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-78-on-mar-20th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $50 to $78 on, Mar 20th, 2018.

Alethia has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $60 on, Thursday, January 25th, 2018

Publication Contributing Sources